| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/22/2007 | US20070066576 Compounds which modulate 2OG (2-oxoglutarate) dependent oxygenases, in particular prolyl hydroxylases; may be useful as modulators of HIF (hypoxia inducible factor) alpha (HIF- alpha ) prolyl hydroxylase; for example, analogues of 2-oxoglutarate, N-phenoxy-acetyl-(L)-alanine-hydroxamide |
| 03/22/2007 | US20070066575 Methods and compositions for mitigating pain |
| 03/22/2007 | US20070066574 Myo-inositol hexaphosphate for topical use |
| 03/22/2007 | US20070066573 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 03/22/2007 | US20070066572 Neuroprotection by positively-charged nitroxides |
| 03/22/2007 | US20070066571 Novel bisphosphonates having anti-inflammatory and/or pain-killing properties |
| 03/22/2007 | US20070066570 Methods for treating sleep disorders |
| 03/22/2007 | US20070066569 using anisole as solvent; reacting amino carboxylic acid with phosphorous acid and a halophosporous compound |
| 03/22/2007 | US20070066568 Involuntary weight loss and/or hypogonadism, central nervous system injuries and chronic wounds |
| 03/22/2007 | US20070066567 Use of phospholipid arachidonic acids for increasing muscle mass in humans |
| 03/22/2007 | US20070066566 19,23,24,25,26,27-Hexanor-1alpha-hydroxyvitamin D3 |
| 03/22/2007 | US20070066565 Cyclic maltosylmatose |
| 03/22/2007 | US20070066564 Sulfotransferase inhibitor |
| 03/22/2007 | US20070066563 alkaline deproteination and subsequent elimination of water-soluble components consists in that the so obtained insoluble glucan is subsequently hydrated by wet grinding; heat sterilizing, results in a fungal polysaccharide with the beta -(1,3)-D-bond in the principal chain |
| 03/22/2007 | US20070066561 Drug delivery and targeting with vitamin B12 conjugates |
| 03/22/2007 | US20070066560 Partial and full agonists of A1 adenosine receptors |
| 03/22/2007 | US20070066559 Administering a side-effect-avoiding dosage of a 1-alkoxyadenosine, excluding 2-methoxyadenosin; treating neuropathic pain and pain caused associated with inflammation or tissue damage |
| 03/22/2007 | US20070066555 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
| 03/22/2007 | US20070066553 Immunostimulatory nucleic acid molecules |
| 03/22/2007 | US20070066549 Modified antisense oligonucleotide; antitumor and anticancer agents |
| 03/22/2007 | US20070066548 Globin variant gene methods and compositions |
| 03/22/2007 | US20070066546 Compositions for the reversible thioesterification of signaling proteins and methods of using same |
| 03/22/2007 | US20070066545 Vaginal compositions for treating pelvic tissue infections and traumas |
| 03/22/2007 | US20070066544 3-Decladinosyl 9a-n-carbamoyl and 9a-n-thiocarbamoyl derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a |
| 03/22/2007 | US20070066543 Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity |
| 03/22/2007 | US20070066542 Novel imidazole derivatives, their preparation and their use as medicaments |
| 03/22/2007 | US20070066541 Compositions and methods for the intraocular transport of therapeutic agents |
| 03/22/2007 | US20070066540 Growth Hormone Secretagogue Receptor Type 1A Agonists |
| 03/22/2007 | US20070066536 Methods for treating hormone associated conditions using a combination of LHRH antagonists and specific estrogen receptor modulators |
| 03/22/2007 | US20070066533 Cell adhesion inhibitors |
| 03/22/2007 | US20070066532 Compositions and methods for treatment of muscle pain and muscle wasting |
| 03/22/2007 | US20070066528 Methods and compositions for treating polycystic ovary syndrome |
| 03/22/2007 | US20070066524 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/22/2007 | US20070066517 Composition and method for treating graft-versus-host disease |
| 03/22/2007 | US20070066513 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization |
| 03/22/2007 | US20070066512 Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels |
| 03/22/2007 | US20070066440 Automatic transmission |
| 03/22/2007 | US20070065921 Methods and products related to producing low molecular weight heparin |
| 03/22/2007 | US20070065908 antiinflammatories, antiviral agents; coadministering with antibiotic; surface decontamination |
| 03/22/2007 | US20070065885 Methods for shp1 mediated neuroprotection |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/22/2007 | US20070065527 Activated citrus peel extract |
| 03/22/2007 | US20070065526 Methods and compositions comprising Panax species |
| 03/22/2007 | US20070065524 Pharmaceutical composition containing guaiacol derivatives and syringol derivatives extracted from natural plant vinegar |
| 03/22/2007 | US20070065522 Administration of high potency platinum compound formulations by inhalation |
| 03/22/2007 | US20070065521 Composition and method for treating iron deficiency anemia |
| 03/22/2007 | US20070065517 Modafinil Pharmaceutical Compositions |
| 03/22/2007 | US20070065516 Composition improved in the solubility or oral absorbability |
| 03/22/2007 | US20070065513 Stable lansoprazole formulation |
| 03/22/2007 | US20070065512 Modified and immediate release formulations of memantine |
| 03/22/2007 | US20070065511 Controlled delivery creatine formulations and method of using the same |
| 03/22/2007 | US20070065510 Novel controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum |
| 03/22/2007 | US20070065509 Comprises ciprofloxacin and hydroxypropylmethylcellulose for improving visocisty |
| 03/22/2007 | US20070065508 Composition Comprising Vitamin B12 and Acid Reducing Agent and Uses Thereof |
| 03/22/2007 | US20070065507 For treatment of osteoporosis is formulated with an amount of a polydimethylsiloxane antifoam agent, and an antacid, a vitamin D derivative, or a calcium supplement; for reducing foaming in the stomach, leading to reduced reflux and oesophageal irritation |
| 03/22/2007 | US20070065504 Inserting solid dosage form, comprising hard fats that melt body temperature surrounded by solid gelatin capsule, comprising antifungal (miconazole nitrate) or antibacterial agents (metronidazole) after patient awakens until thirty minutes prior to patient sleeps |
| 03/22/2007 | US20070065501 Method for banding hard capsules using hydroxypropylmethyl cellulose (HPMC) as a base |
| 03/22/2007 | US20070065500 Northern white kidney bean extract and red kidney bean extract in combination with green tea extract in the treatment of obesity |
| 03/22/2007 | US20070065498 Encapsulated arsenic drugs |
| 03/22/2007 | US20070065497 Combination and method using EDTA combined with glutathione in the reduced state encapsulated in a liposome to facilitate the method of delivery of the combination as an oral, topical, intraoral or transmucosal, for anti-thrombin effect and for anti-platelet aggregation and measurement of efficacy |
| 03/22/2007 | US20070065496 Dermal therapeutic system comprising 2-(3-benzophenyl)propionic acid |
| 03/22/2007 | US20070065495 Transdermal hormone delivery system: compositions and methods |
| 03/22/2007 | US20070065494 Formulations and Methods for Enhancing the Transdermal Penetration of a Drug |
| 03/22/2007 | US20070065493 External patch containing estrogen and/or progestogen |
| 03/22/2007 | US20070065492 Cladribine formulations for improved oral and transmucosal delivery |
| 03/22/2007 | US20070065487 Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof |
| 03/22/2007 | US20070065486 Migraine remedy |
| 03/22/2007 | US20070065485 Therapeutic delivery of carbon monoxide |
| 03/22/2007 | US20070065481 Coatings including natural biodegradable polysaccharides and uses thereof |
| 03/22/2007 | US20070065472 Benzyl-1,3-thiazolidine-2,4-dione compounds for stimulating or inducing the growth and/or for reducing the loss of keratin fibers |
| 03/22/2007 | US20070065471 Cosmetic/dermatological applications of PPAR receptor activators |
| 03/22/2007 | US20070065467 Immunostimulatory nucleic acid molecules for activating dendritic cells |
| 03/22/2007 | US20070065465 Conjugate vaccines for the prevention of dental caries |
| 03/22/2007 | US20070065463 Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions |
| 03/22/2007 | US20070065456 Nutritional supplements |
| 03/22/2007 | US20070065451 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 03/22/2007 | US20070065449 Method of treating cancer, especially soft tissue sarcoma utilizing gemcitabine in combination with docetaxel and anti-VEGF therapy (bevacizumab) |
| 03/22/2007 | US20070065443 Fructoseamine 3 kinase and the formation of collagen and elastin |
| 03/22/2007 | US20070065442 Compositions and methods for treating hyperimmune response in the eye |
| 03/22/2007 | US20070065410 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/22/2007 | US20070065400 Treatment of tumor metastases and cancer |
| 03/22/2007 | US20070065398 Photoactivatable composition and uses thereof |
| 03/22/2007 | US20070065386 Use of oligosaccharides in cosmetic, food or dermatological compositions for stimulating the differentiation of epidermal cell |
| 03/22/2007 | US20070065380 provitamin C is prepared from Lycium fruit extract; decomposed in the body to produce vitamin C; improved stability in the body and prolonged life in the body; bioavailability; vitamin C-fortified food; apply to skin protecting from ultraviolet damage, wrinkles and aging |
| 03/22/2007 | US20070065377 Composition for promoting synthesis of collagen, and composition for external preparation for skin comprising the same |
| 03/22/2007 | US20070065374 Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations |
| 03/22/2007 | US20070065373 Mucoactive agents for treating a pulmonary disease |
| 03/22/2007 | US20070065370 Suspension aerosol formulationis of pharmaceutical products |
| 03/22/2007 | US20070065366 Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation |
| 03/22/2007 | US20070065365 Abuse-resistant transdermal system |
| 03/22/2007 | US20070065364 Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same |
| 03/22/2007 | DE102005044817A1 Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament Substituted 4-Phenyltetrahydroisochinoline, processes for their preparation, their use as a medicament, and medicament containing them |
| 03/22/2007 | DE102005044319A1 2-(Aminomethyl)-5-Chlor-Benzylamid-Derivate und ihre Verwendung als Hemmstoffe des Gerinnungsfaktors Xa 2- (Aminomethyl) -5-chloro-benzylamide derivatives and their use as inhibitors of coagulation factor Xa |
| 03/22/2007 | DE102005042828A1 Ausgewählte CGPR-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGPR antagonists, process for their preparation and their use as medicaments |
| 03/22/2007 | DE102005041570A1 Hoch verzweigte Reagenzien zur Modifaktion von Biopharmazeutika, deren Herstellung und Anwendung Highly branched reagents for Modifaktion of biopharmaceuticals, their preparation and use |
| 03/22/2007 | DE102005039541A1 3-Oxo-indazol-quadratsäurederivate 3-oxo-indazole-square acid derivatives |
| 03/22/2007 | CA2845251A1 Compositions for the therapy of bcl2-associated cancers and methods of preparation thereof |
| 03/22/2007 | CA2820201A1 Identification of tumor-associated antigens for diagnosis and therapy |
| 03/22/2007 | CA2625791A1 Combination of bioavailable methionine with at least one essential oil |